Free tool
Drugs in development
Last checked: Nov 20, 2026Latest source record: rebuilt Nov 18, 2026Source: ClinicalTrials.govMethods & limitations
Drugs in development
3,685
Not FDA-approved
In Phase 3
1,424
Highest phase reached
Matching your filters
3,685
3,685 drugs in development
Names, sponsors and conditions come from the trial records. Click a drug for its trials.
- MNV-201Phase 21 trial
Minovia Therapeutics Ltd. · Mitochondrial Diseases, Pearson Syndrome
- MocaciclibQ901Phase 21 trial
Qurient Co., Ltd. · Advanced Cancer, Metastatic Cancer
- MPB-1734DMB025Phase 21 trial
MegaPro Biomedical Co. Ltd. · Solid Tumor, Unspecified, Adult
- MR001Phase 21 trial
Shenzhen Majory Biotechnology Co., Ltd. · Pancreatic Ductal Adenocarcinoma (PDAC)
- MRG-001Phase 21 trial
MedRegen LLC · Alcoholic Hepatitis, Acute Alcoholic Hepatitis
- MRG007Phase 21 trial
Lepu Biopharma Co., Ltd. · Advanced Colorectal Cancer
- MS-553Phase 21 trial
MingSight Pharmaceuticals, Inc · CLL (Chronic Lymphocytic Leukemia), SLL (Small Lymphocytic Lymphoma)
- MT-201Phase 21 trial
Mirador Therapeutics, Inc. · Inflammatory Bowel Disease (IBD), Ulcerative Colitis (UC), Crohn's Disease
- MT-4561Phase 21 trial
Tanabe Pharma America, Inc. · Head and Neck Squamous Cell Carcinoma (HNSCC), Non-small Cell Lung Cancer (NSCLC), Esophageal Cancer
- MT-501Phase 21 trial
Mirador Therapeutics, Inc. · Inflammatory Bowel Disease (IBD), Ulcerative Colitis (UC), Crohn's Disease
- MT101-5Phase 21 trial
Mthera Pharma Co., Ltd. · Parkinson's Disease
- MT1988Phase 21 trial
Monument Therapeutics Limited · Clinical High Risk for Psychosis (CHR)
- MT200605Phase 21 trial
Shaanxi Micot Pharmaceutical Technology Co., Ltd. · Acute Ischemic Stroke
- MT218Phase 21 trial
Songqi Gao · MRI Scan
- MTX-001human amniotic fluidPhase 21 trial
Merakris Therapeutics · Venous Stasis Ulcer, Venous Leg Ulcer
- MTX-463Phase 21 trial
Mediar Therapeutics · Idiopathic Pulmonary Fibrosis
- MTX-474Phase 21 trial
Mediar Therapeutics · Diffuse Cutaneous Systemic Sclerosis
- MTX101Phase 21 trial
Manistee Therapeutics · Migraine
- MVA-209-FSPPhase 21 trial
Nouscom SRL · Solid Tumor, Adult
- MWX203Phase 21 trial
Shanghai Minwei Biotechnology Co., Ltd · Mixed Dyslipidemia
- MZE782Phase 21 trial
Maze Therapeutics · Phenylketonuria (PKU)
- MZE829Phase 21 trial
Maze Therapeutics · Proteinuric Kidney Disease
- N17350Phase 21 trial
Onchilles Pharma Inc · Neoplasms, Solid Tumor, Breast Neoplasms, Triple-Negative, Squamous Cell Carcinoma of Skin
- Nab-placlitaxelPhase 21 trial
BioNTech SE · Locally Advanced Breast Cancer, Triple Negative Breast Cancer, Metastatic Triple Negative Breast Cancers
- NadunolimabCAN04Phase 21 trial
Cantargia AB · Triple Negative Breast Cancer
- nangibotideLR12Phase 21 trial
Inotrem · Shock, Septic
- narmafotinibPhase 21 trial
Amplia Therapeutics Limited · Pancreatic Cancer Metastatic
- NAV-240Phase 21 trial
Navigator Medicines, Inc. · Hidradenitis Suppurativa (HS)
- NazartinibEGF816Phase 21 trial
Novartis · Advanced Solid Tumors Which Are cMET-dependent
- NB-4746Phase 21 trial
Nura Bio · Amyotrophic Lateral Sclerosis (ALS)
- NBI-1065890Phase 21 trial
Neurocrine Biosciences · Tardive Dyskinesia
- NBI-1070770Phase 21 trial
Neurocrine Biosciences · Major Depressive Disorder
- NBI-1117567Phase 21 trial
Neurocrine Biosciences · Alzheimer's Disease
- NBI-1117570Phase 21 trial
Neurocrine Biosciences · Schizophrenia
- NBIP-01435Phase 21 trial
Neurocrine Biosciences · Congenital Adrenal Hyperplasia
- NBQ72SQBS10072SPhase 21 trial
Nantong Bencao Quadriga Medical Technology Co. Ltd. · Breast Cancer
- nC-001Phase 21 trial
nephCentric · CHRONIC HYPONATREMIA
- NCR100Phase 21 trial
Nuwacell Biotechnologies Co., Ltd. · Knee Osteoarthritis
- NCR101Phase 21 trial
Nuwacell Biotechnologies Co., Ltd. · Interstitial Lung Disease (ILD)
- NCR102Phase 21 trial
Nuwacell Biotechnologies Co., Ltd. · Acute Graft-versus-Host Disease
- NCS-01Phase 21 trial
NC Medial Research Inc · Ischemic Stroke
- ND-003Phase 21 trial
Shenzhen NewDEL Biotech, Co., Ltd · Idiopathic Pulmonary Fibrosis (IPF)
- ND0612ND0612HPhase 21 trial
NeuroDerm Ltd. · Parkinson's Disease
- NDI-101150Phase 21 trial
Nimbus Saturn, Inc. · Solid Tumor, Renal Cell Carcinoma (Kidney Cancer), Gastric and Gastroesophageal Junction (GEJ) Adenocarcinoma
- NDI-219216Phase 21 trial
Nimbus Wadjet, Inc. · Advanced Solid Tumors Cancer, MSI-H Cancer
- NDX-3315Phase 21 trial
NexEos Diagnostics, Inc. · Eosinophilic Esophagitis
- NDX-3324Phase 21 trial
NexEos Diagnostics, Inc. · Eosinophilic Esophagitis
- NemvaleukinALKS 4230Phase 21 trial
Mural Oncology, Inc · Advanced Solid Tumor
- NEO-201Phase 21 trial
Precision Biologics, Inc · Non Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma, Cervical Cancer
- NEO212POH-TMZPhase 21 trial
Neonc Technologies, Inc. · Diffuse Astrocytoma, IDH-Mutant, Glioblastoma, IDH-wildtype, Brain Metastases, Adult
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.